ClearBridge Investments
KDNY

ClearBridge Investments’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

ClearBridge Investments’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44,231
Closed -$341K – 1135
2019
Q2 		$341K Sell
44,231
-318
-0.7% -$4.84K ﹤0.01% 716
2019
Q1 		$887K Buy
44,549
+258
+0.6% +$4.5K ﹤0.01% 685
2018
Q4 		$585K Sell
44,291
-43
-0.1% -$859 ﹤0.01% 714
2018
Q3 		$1.63M Buy
44,334
+20
+0% +$642 ﹤0.01% 696
2018
Q2 		$1.55M Sell
44,314
-456
-1% -$17.5K ﹤0.01% 619
2018
Q1 		$2.08M Buy
44,770
+8
+0% +$293 ﹤0.01% 579
2017
Q4 		$1.68M Buy
44,762
+45
+0.1% +$1.97K ﹤0.01% 604
2017
Q3 		$2.38M Sell
44,717
-103
-0.2% -$6.12K ﹤0.01% 575
2017
Q2 		$2.56M Buy
44,820
+292
+0.7% +$14.7K ﹤0.01% 563
2017
Q1 		$2.39M Buy
44,528
+2
+0% +$113 ﹤0.01% 593
2016
Q4 		$2.54M Buy
44,526
+4
+0% +$242 ﹤0.01% 596
2016
Q3 		$2.77M Sell
44,522
-114
-0.3% -$8.06K ﹤0.01% 589
2016
Q2 		$2.52M Buy
44,636
+5
+0% +$304 ﹤0.01% 614
2016
Q1 		$2.86M Buy
44,631
+7
+0% +$566 ﹤0.01% 594
2015
Q4 		$6.28M Sell
44,624
-7
-0% -$951 0.01% 526
2015
Q3 		$4.32M Buy
44,631
+14
+0% +$1.67K 0.01% 585
2015
Q2 		$6.77M Buy
+44,617
New +$7.37M 0.01% 537

Other funds holding KDNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ClearBridge Investments's KDNY Position: Q3 2019 in Review

ClearBridge Investments sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2019, closing a stake of 44,231 shares — an estimated $341K sold.

ClearBridge Investments first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $6.77M in Q2 2015. 88 funds tracked by Wall St. Rank hold KDNY as of Q3 2019.

  • ClearBridge Investments reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • ClearBridge Investments sold 44,231 Chinook Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $341K.
  • ClearBridge Investments first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
  • ClearBridge Investments's Chinook Therapeutics, Inc. Common Stock position peaked at $6.77M in Q2 2015.
  • 88 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2019.

Based on ClearBridge Investments's 13F filing for Q3 2019, filed 14 Nov 2019.